Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention

Neurourology and Urodynamics

Volumn 28, Issue 1, 2009, Pages 78-81

  Liu, Hsin Tzu ^a   Kuo, Hann Chorng ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Bladder volume; Nerve growth factor; Overactive bladder

Indexed keywords

CREATININE; NERVE GROWTH FACTOR; BIOLOGICAL MARKER;

ADULT; ANALYTICAL ERROR; ARTICLE; BLADDER CAPACITY; BLADDER DISTENSION; BLADDER FILLING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; OVERACTIVE BLADDER; PROTEIN SYNTHESIS; URINALYSIS; AGED; BLADDER; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; UPREGULATION; URINE; URODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; UP-REGULATION; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 59449087115     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20599     Document Type: Article

References (29)

1. Abrams P, Kelleher CJ, Kerr LA, et al. Overactive bladder significantly affects quality of life. Am J Manag Care 2000;6:S580-90.
2. DeWatcher S, Wyndale JJ. Frequency volume chart: A tool to evaluate bladder sensation. Neurourol Urodyn 2003;22:638-43.
3. Nixon A, Colman S, Sabounjian L, et al. Validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005;174:604-7.
4. Yamaguchi O, Honda K, Nomiya M, et al. Defining overactive bladder as hypersensitivity. Neurourol Urodyn 2007;26:904-7.
5. Kuo HC. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms. Urology 2007;70:272-6.
6. Romanzi LJ, Groutz A, Heritz DM, et al. Involuntary detrusor contractions: Correlation of urodynamic data to clinical categories. Neurourol Urodyn 2001;20:249-57.
7. Steers WD, Kolbeck S, Creedon D, et al. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991;88:1709-15.
8. Tuttle JB, Steers WD, Albo M, et al. Neural input regulates tissue NGF and growth of the adult urinary bladder. J Auton Nerv Syst 1994;49:147-58.
9. Dupont MC, Spitsberegen JM, Kim KB, et al. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001; 166:1111-8.
10. Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997;79:572-7.
11. Okragly AJ, Niles AL, Saban R, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 1999;161: 438-41.
12. Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004;5:150-6.
13. Kim JC, Park EY. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006;175:1773-6.
14. Yokoyama T, Kumon H, Nagai A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn 2008;27:417-20.
15. Liu HT, Kuo HC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of patients with overactive bladder. J Urol 2008;179:2270-74.
16. Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 2008; [Epub med ahead of print].
17. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-81.
18. Cockayne DA, Hamilton SG, Zhu OM, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000;407: 1011-5.
19. Ouslander JG. Management of overactive bladder. N Engl J Med 2004;350: 786-99.
20. Morrison J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A, editors. Incontinence, 2nd edition. Plymouth, UK: Health Publication Ltd; 2002.
21. Coolsaet BL, Van Duyl WA, Van Os-Bossagh P, et al. New concepts in relation to urge and detrusor activity. Neurourol Urodyn 1993;12:463-71.
22. Namasivayam S, Eardley I, Morrison JFB. A novel in vitro bladder-pelvic nerve afferent model in the rat. Br J Urol 1998;82:902-5.
23. Giannantoni A, Di Stasi SM, Nardicchi V, et al. Botulinum A toxin injection into the detrusor decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 2006;175:2341-4.
24. Steers WD, Tuttle JB. Mechanisms of diseases: The role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006; 3:101-10.
25. Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 2002;4:S7-18.
26. Charrura A, Cruz CD, Cruz F, et al. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 2007;177:1537-41.
27. Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channel. EMBO J 2005;24:4211-23.
28. Zvara P, Vizzard MA. Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol 2007;7:9-19.
29. Birder LA, Wolf-Johnston A, Griffiths D, et al. Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn 2007;26:405-9.